Proton Therapy System Available in Multi-Room Configuration
|
By MedImaging International staff writers Posted on 02 Oct 2019 |

Image: The ProBeam 360° system is now available in multi-room configurations (Photo courtesy of Varian Medical Systems).
The Varian Medical Systems (Varian, Palo Alto, CA, USA) ProBeam 360° system is now available in a multi-room (one to five treatment or research rooms) configuration, which allows cancer centers to tailor the system to meet clinical, research, and capacity needs. Treatment room options include rotating gantries, fixed beam rooms, or eye treatment rooms. Research rooms are available for non-clinical proton beam applications.
The ProBeam 360° system features an extremely powerful cyclotron accelerator, iterative cone-beam computerized tomography (CT) imaging, and high-definition pencil-beam scanning. The 360° rotating gantry enables efficient intensity-modulated proton therapy (IMPT) and faster treatment times by minimizing the need for patient repositioning, thus allowing high-quality cone-beam CT (CBCT) imaging from most angles. RapidScan technology simplifies the process of motion management by delivering each field in a single breath-hold, a capability that increases the number of patients who can comply with breath-hold treatments.
The high-definition pencil-beam scanning technology gives clinicians the ability to deliver dose precisely within the contours of a tumor, minimizing dose to healthy tissue. An iterative CBCT capability enables adaptive precision radiation therapy (RT) during a course of treatment. The system also offers clinicians a viable path to potential next-generation treatments such as Flash therapy. In addition, the ProBeam 360° System offers a 50% smaller volume, a 30% smaller footprint, and 25% lower vault construction cost than Varian’s previous multi-room solution.
“Proton therapy plays an important role in the fight against cancer. The multi-room configuration of ProBeam 360° system provides clinics the flexibility to meet their treatment needs, while also increasing access for patients to proton therapy,” said Kolleen Kennedy, chief growth officer and president of Proton Therapy Solutions at Varian. “Increasing access to advanced treatments like proton therapy is an important step towards achieving our vision of a world without fear of cancer.”
Protons are generated by accelerators in the range of 70 to 250 MeV; by adjusting the energy of the protons during application of treatment, the cell damage due to the proton beam is maximized within the tumor itself. And due to their relatively large mass, protons also have little lateral side scatter in the tissue, staying focused on the tumor. Tissues closer to the surface of the body than the tumor receive reduced radiation, while tissues deeper within the body receive very few protons, so that the dosage becomes immeasurably small.
The ProBeam 360° system features an extremely powerful cyclotron accelerator, iterative cone-beam computerized tomography (CT) imaging, and high-definition pencil-beam scanning. The 360° rotating gantry enables efficient intensity-modulated proton therapy (IMPT) and faster treatment times by minimizing the need for patient repositioning, thus allowing high-quality cone-beam CT (CBCT) imaging from most angles. RapidScan technology simplifies the process of motion management by delivering each field in a single breath-hold, a capability that increases the number of patients who can comply with breath-hold treatments.
The high-definition pencil-beam scanning technology gives clinicians the ability to deliver dose precisely within the contours of a tumor, minimizing dose to healthy tissue. An iterative CBCT capability enables adaptive precision radiation therapy (RT) during a course of treatment. The system also offers clinicians a viable path to potential next-generation treatments such as Flash therapy. In addition, the ProBeam 360° System offers a 50% smaller volume, a 30% smaller footprint, and 25% lower vault construction cost than Varian’s previous multi-room solution.
“Proton therapy plays an important role in the fight against cancer. The multi-room configuration of ProBeam 360° system provides clinics the flexibility to meet their treatment needs, while also increasing access for patients to proton therapy,” said Kolleen Kennedy, chief growth officer and president of Proton Therapy Solutions at Varian. “Increasing access to advanced treatments like proton therapy is an important step towards achieving our vision of a world without fear of cancer.”
Protons are generated by accelerators in the range of 70 to 250 MeV; by adjusting the energy of the protons during application of treatment, the cell damage due to the proton beam is maximized within the tumor itself. And due to their relatively large mass, protons also have little lateral side scatter in the tissue, staying focused on the tumor. Tissues closer to the surface of the body than the tumor receive reduced radiation, while tissues deeper within the body receive very few protons, so that the dosage becomes immeasurably small.
Latest Nuclear Medicine News
- Radiotherapy Professionals Embrace AI as a Clinical Support Tool
- Second PSMA PET Identifies Disease in More Than Half of Negative Cases
- New PET Tracer Detects DVT and Pulmonary Embolism in One Scan
- Targeted PET Platform Guides Osteosarcoma Resection and Margin Verification
- Portable PET System Enables Real-Time Bedside Guidance for Biopsies and Ablations
- AI Model Predicts Radiation Dose Before Prostate Cancer Therapy
- Vault-Free Radiosurgery Platform Expands Access to Cranial Tumor Care
- MR-Guided Cardiac Mapping System Enables Radiation-Free Procedures
- New Imaging Tool Sheds Light on Tumor Fat Metabolism
- PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
- Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
- Cancer “Flashlight” Shows Who Can Benefit from Targeted Treatments
- PET Imaging of Inflammation Predicts Recovery and Guides Therapy After Heart Attack
- Radiotheranostic Approach Detects, Kills and Reprograms Aggressive Cancers
- New Imaging Solution Improves Survival for Patients with Recurring Prostate Cancer
- PET Tracer Enables Same-Day Imaging of Triple-Negative Breast and Urothelial Cancers
Channels
Radiography
view channel
Computational X-Ray Technique Enables High-Resolution, Low-Dose Radiography
Reducing radiation in medical X-ray imaging remains a persistent challenge because dose reductions often degrade spatial resolution and diagnostic confidence. This is especially critical in pediatrics,... Read more
AI Tool Predicts Five-Year Breast Cancer Risk from Mammograms
Breast cancer risk assessment during routine screening is difficult because many women who develop the disease have no known genetic mutations or family history. Static risk tools provide limited discrimination... Read moreMRI
view channel
Rapid AI System Detects and Classifies Brain Tumor Subtypes on MRI
Brain tumors are a major cause of cancer mortality worldwide, with roughly a quarter of a million deaths each year. Early detection and accurate subtype classification on magnetic resonance imaging are... Read more
Advanced MRI Reveals Structural Brain Changes Linked to Better Cognitive Health
Objective, noninvasive measures that capture subtle, training-related changes in adult brain structure remain limited in routine clinical practice. Quantifying neuroplasticity with precision is especially... Read moreUltrasound
view channel
Simple 2D Ultrasound Tool Accurately Estimates Placental Volume
Stillbirth remains a major cause of perinatal loss, with about 21,000 cases annually in the United States. Although placental abnormalities are linked to adverse pregnancy outcomes, routine monitoring... Read more
Portable 3D Ultrasound System Enables Reproducible Breast Cancer Monitoring
Breast cancer can develop between annual mammograms, and these interval cancers account for 20% to 30% of cases and tend to be more aggressive. The challenge is pronounced in people with dense breast tissue.... Read moreGeneral/Advanced Imaging
view channel
PET/CT Improves Diagnosis and Management of Fever of Unknown Origin
Fever of unknown origin (FUO) is persistent fever without an identifiable cause and remains difficult to diagnose because potential etiologies are broad and no single gold-standard pathway exists.... Read more
New PE-RADS Framework Standardizes Pulmonary Embolism Imaging Reports
Pulmonary embolism is a sudden blockage of the lung’s blood vessels that reduces pulmonary blood flow, can strain the right hear,t and may be fatal if untreated. Patients often present with shortness of... Read moreImaging IT
view channel
Ambient AI Reporting Platform Streamlines Radiology Reporting
Radiology departments face growing imaging volumes and staffing shortages, creating reporting bottlenecks and pressure to maintain turnaround times. Conventional dictation tools document findings after... Read more
Interactive AI Tool Supports Explainable Lung Nodule Assessment
Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read moreIndustry News
view channel
GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026
Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
GE HealthCare Highlights AI-Supported Radiation Therapy Tools at ESTRO 2026
At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare is highlighting Intelligent Radiation Therapy (iRT), MIM Software innovations, and BK Medical surgical... Read more







